Subsidiaries

 

AddBIO AB

AddBIO AB develops and commercializes products for local drug delivery, improving the performance of implants. The company holds the rights to two technology platforms in this area. Primary development focus is on an implant coating, called FibMat. AddBIO’s products reduce complications and revision rates of bone implants. The products provide local delivery of drugs, and so increase the early stability of the implant and enhance the holding power of the bone. It can thereby reduce healthcare expenses by improving functionality and extending the life time of bone implants.

Optovent AB/Archaea Pharma AB

Optovent AB develops and commercializes research based innovations within drug delivery. The primary development project is carried out within Optovent’s subsidiary, Archaea Pharma. Archaea Pharma is developing a drug delivery platform for targeted and local delivery of cytotoxic drugs directly to the tumor site. This has the potential to both improve treatment effectiveness as well as reduce unwanted side effects

Spago Imaging AB

Spago Imaging AB is a Swedish contrast agent company  dedicated  to the development of MRI contrast agents for the early and specific detection and diagnosis of cancer. SPAGO focuses on developing contrast agents based on a proprietary nanoparticle based platform.

SyntheticMR AB

SyntheticMR AB has developed a proprietary analytical and visualization tools enabling synthetic MRI which help clinicians to reduce the time needed for MR-imaging dramatically, thereby increasing patient throughput. Synthetic MR synthesizes all possible MRI parameters from a simple general scan, eliminating the extra time needed to perform multiple scans. Other advantages of synthetic MR are improved performance from current image analysis systems and the possibility to analyze fewer but more precise images.

OptoQ AB

OptoQ AB is a medical device company that markets and sells technology platforms for safe and cost effective patient-monitoring. The company has developed a light based fibre-optic patient monitoring technique focusing on non-invasive measurement of haemoglobin and other physiological parameters for medical diagnostics.